# FDA Inspection 1068761 - Regeneron Pharmaceuticals Inc - September 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/c7651fd9-26b7-481f-8b88-a8d9649f18dd
Source feed: FDA_Inspections

> FDA Inspection 1068761 for Regeneron Pharmaceuticals Inc on September 17, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068761
- Company Name: Regeneron Pharmaceuticals Inc
- Inspection Date: 2018-09-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1292476 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/f32684d9-704d-40e5-96c3-6e4ae998055e)
- [FDA Inspection 1292476 - 2025-12-10](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/73a221d2-f485-4743-87ce-67ffd7532740)
- [FDA Inspection 1232732 - 2024-05-01](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/b8b32e56-a0a8-49bd-8b60-00af143c362b)
- [FDA Inspection 1228712 - 2024-01-19](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/a36b4ea2-1103-4135-b2fe-510e643f7ea4)
- [FDA Inspection 1156180 - 2021-10-15](https://www.keypedia.com/records/fda_inspections/regeneron-pharmaceuticals-inc/e66f35fc-9862-4dea-a281-af38a78097ea)

Company: https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/fbb2cea0-65e4-4da9-9c5f-eea90c33a84f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c